Alzheimer’s Disease: What You Need to Know

What Is Alzheimer's Disease?

Alzheimer’s disease is a progressive brain disorder that gradually affects memory, thinking, behavior, and the ability to perform everyday activities. It accounts for approximately 60–80% of all dementia cases. In the United States alone, more than six million people live with Alzheimer’s disease, and worldwide over 55 million people are affected by dementia.

Although strongly associated with aging, Alzheimer’s is a complex condition influenced by genetics, vascular health, lifestyle, inflammation, and overall brain resilience.

The disease develops gradually over many years and affects memory, thinking, and behavior, often beginning long before symptoms appear. While current treatments can help manage symptoms and may modestly slow progression in some cases, there is currently no cure.

Dementia vs. Alzheimer’s Disease

Dementia is a general term describing a decline in cognitive function severe enough to interfere with daily life. Alzheimer’s disease is the most common cause of dementia, but other causes include vascular dementia, Lewy body dementia, frontotemporal, and mixed dementia (very common). Understanding the difference helps clarify diagnosis, treatment, and expectations.

History of Alzheimer’s Disease

The first case of Alzheimer’s disease was described in 1906 by German psychiatrist Alois Alzheimer, who studied a 51-year-old patient, Auguste Deter, who experienced severe memory loss, confusion, and behavioral changes.

After her death at age 55, Alzheimer examined her brain and discovered two abnormal structures: amyloid plaques and neurofibrillary tangles. These changes disrupt communication between neurons and eventually lead to cell damage and loss. These structures remain the defining characteristics of Alzheimer’s disease.

However, later research showed that some individuals can have these brain changes without developing dementia, indicating that plaques and tangles alone do not fully determine whether symptoms appear.

What Happens in the Brain

Alzheimer’s disease involves several structural and biological changes:

• Amyloid plaques – clusters of beta-amyloid protein that accumulate between neurons

• Neurofibrillary tangles – twisted fibers of tau protein inside neurons

• Loss of synapses and neurons – the connections between brain cells weaken

• Brain atrophy – shrinkage of key regions, especially the hippocampus and cortex

These abnormalities disrupt communication between brain cells, causing memory loss and cognitive decline. The hippocampus, which is critical for forming and retrieving memories, is often affected early in the disease.

The Amyloid Hypothesis and Its Limitations

For decades, Alzheimer’s research focused on the amyloid hypothesis, which proposes that beta-amyloid accumulation is the primary cause of the disease. Amyloid plaques are a hallmark of Alzheimer’s disease, evidence suggests they are not sufficient on their own to cause dementia.

• Some individuals have extensive plaques but remain cognitively normal

• Drugs that remove plaques provide only modest benefits

• Alzheimer’s disease is also strongly associated with vascular disease, inflammation, metabolic disorders, and lifestyle factors

This indicates that Alzheimer’s is multifactorial, influenced by genetics, vascular health, lifestyle, inflammation, and brain resilience—not amyloid alone. Targeting plaques alone has had limited success, which is why prevention increasingly emphasizes overall brain and cardiovascular health.

Cognitive Reserve and the Nun Study

The concept of cognitive reserve is one of the most important discoveries in Alzheimer’s research. Cognitive reserve refers to the brain’s ability to compensate for damage, allowing some people to remain cognitively healthy despite significant brain pathology.

The Nun Study, led by David A. Snowdon, followed 678 nuns who underwent regular cognitive testing during life and donated their brains after death. Some nuns remained cognitively normal despite having extensive plaques and tangles, highlighting the protective effect of cognitive reserve.

Factors that may increase cognitive reserve include:

• Education

• Mental stimulation and lifelong learning

• Bilingualism or multilingualism*

• Physical activity

• Social engagement

• Overall brain and cardiovascular health

*Some studies suggest bilingualism and multilingualism may help delay the onset of dementia symptoms by strengthening cognitive reserve and promoting neural adaptability.

This concept helps explain why some individuals develop dementia while others with similar brain pathology show symptoms only after a delay.

Symptoms and Stages

Alzheimer’s disease progresses gradually. Average survival after diagnosis is 4–8 years, although some live up to 20 years.

1. Preclinical Stage

What happens: Brain changes begin years before symptoms appear.

Care considerations: Maintain regular physical activity, prioritize sleep, manage cardiovascular risk factors, and follow brain-healthy lifestyle habits.

2. Early Stage

What happens: Mild memory problems may develop, along with difficulty finding words, misplacing items, and challenges with planning or organization.

Care considerations: Simplify tasks when needed, encourage independence, and begin legal and financial planning while the individual can actively participate in decision-making.

3. Middle Stage

What happens: Symptoms become more noticeable and may include increasing confusion, personality changes, difficulty recognizing people, trouble managing daily tasks, wandering, and changes in sleep or mood.

Care considerations: Provide increasing supervision and assistance with daily activities while maintaining routines, safety, and emotional support.

4. Late Stage

What happens: Severe cognitive and physical decline occurs, communication becomes limited, and the individual becomes fully dependent on caregivers.

Care considerations: Focus on comfort, dignity, gentle engagement, symptom

management, and discussions about palliative or hospice care when appropriate.

Reversible Causes of Memory Problems

Before diagnosing Alzheimer’s, doctors often evaluate for reversible causes, including:

• Thyroid disorders

• Diabetes

• Depression

• Chronic infections

• Celiac disease

• Hypertension or hypotension

• Vitamin deficiencies

Certain medications can also impair memory:

• Anticholinergics (e.g., diphenhydramine)

• Sleep medications (e.g., zolpidem)

• Benzodiazepines (e.g., diazepam)

• Some antidepressants (e.g., paroxetine)

• Bladder medications (e.g., oxybutynin)

Treating underlying conditions or adjusting medications may improve cognitive function.

Risk Factors

Non-Modifiable

• Age

• Family history

• Genetics (e.g., APOE4 gene increases risk but is not deterministic)

• Traumatic brain injury

• Female sex (women are diagnosed more often than men, partly because women tend to live longer)

Modifiable Risk Factors

Many Alzheimer’s risk factors are closely linked to cardiovascular and metabolic health because the brain depends heavily on healthy blood flow and oxygen delivery.

These include:

• Hypertension*

• Hypotension

• High cholesterol

• Diabetes

• Obesity

• Physical inactivity

• Smoking

• Excess alcohol consumption

• Poor sleep

• Chronic stress

• Depression

• Social isolation

• Poor diet

Conditions that damage blood vessels — including hypertension, diabetes, smoking, and high cholesterol — may impair blood flow to the brain and contribute to cognitive decline and dementia risk.

*Studies show a J-shaped relationship—both very high and very low blood pressure may increase dementia risk. In older adults, treated with antihypertensive medications, optimal systolic blood pressure appears to be around 130–140 mmHg.

Lifestyle Risk Factors

• Poor sleep

• Chronic stress

• Social isolation

• Poor diet

Possible Contributing Factors (Evidence Still Mixed)

• Metals such as iron, copper, zinc, aluminum

• Advanced glycation end products (AGEs) from high-heat cooking

• Gut microbiome and inflammation

High intake of copper from supplements or heavily fortified foods has been associated in some studies with faster cognitive decline when combined with high saturated fat intake.

Iron is essential for oxygen transport and brain metabolism, but excessive iron accumulation may promote oxidative stress in brain tissue.

Some studies have linked higher aluminum levels in drinking water with faster cognitive

decline. A 2011 review concluded that aluminum could be a plausible environmental contributor to Alzheimer’s disease. These findings indicate that environmental exposures could play a role in Alzheimer’s disease, but more research is needed to confirm causality.

Given the potential risks associated with excessive mineral intake, obtaining minerals primarily from whole foods rather than high-dose supplements may be the safest approach unless a deficiency has been diagnosed.

Current Treatments

Symptom-Managing Medications

• Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)

• Memantine

These may temporarily improve memory or slow symptom progression but do not cure the disease.

Disease-Modifying Therapies

Newer drugs target amyloid plaques:

• Lecanemab

• Donanemab

They can reduce plaques and may modestly slow cognitive decline, but benefits are limited and risks include brain swelling and bleeding.

Diet and Brain Health

Diet is one of the most important modifiable influences on brain health. Dietary patterns rich in vegetables, fruits, legumes, whole grains, nuts, and seeds provide fiber, antioxidants, vitamins, minerals, and phytochemicals that help reduce inflammation and oxidative stress—two processes believed to contribute to age-related cognitive decline.

Vegetables, fruits, legumes, whole grains, nuts, and seeds provide fiber, antioxidants, vitamins, minerals, and phytochemicals that help reduce oxidative stress and inflammation while supporting cardiovascular health. Because healthy blood vessels are essential for delivering oxygen and nutrients to the brain, conditions such as hypertension, diabetes, and atherosclerosis are associated with an increased risk of cognitive decline and dementia.

Fiber-rich plant foods may also support brain health through the gut–brain axis. Beneficial gut bacteria ferment dietary fiber into short-chain fatty acids, compounds that help maintain the intestinal barrier, regulate immune function, and may help reduce systemic inflammation.

Key nutrients associated with brain health include:

• Vitamin E from nuts, seeds, and leafy greens

• Folate and other B vitamins from legumes, vegetables, and fortified foods

• Magnesium from leafy greens, beans, and whole grains

• Omega-3 fatty acids from flaxseeds, chia seeds, hemp seeds, and walnuts

Foods commonly associated with brain health include:

• Leafy greens such as spinach, kale, and arugula

• Berries including blueberries, strawberries, and blackberries

• Beans and lentils

• Whole grains such as oats, brown rice, and quinoa

• Nuts and seeds, especially flaxseeds, chia seeds, walnuts, and hemp seeds

• Colorful vegetables rich in antioxidants

Whole-food sources of nutrients are generally preferred over supplements, although vitamin B12 supplementation remains important for individuals following fully plant-based diets.

Coffee and Tea

Moderate intake of caffeinated coffee and tea may also be associated with better long-term cognitive health. A large 2026 prospective cohort study found that caffeinated coffee and tea intake were linked with lower dementia risk and modestly better cognitive function, with the strongest associations at moderate intake levels. A 2024 meta-analysis also found that tea intake was associated with lower dementia risk, while coffee showed a nonlinear pattern, suggesting that moderate intake may be most favorable. However, these studies are observational and cannot prove causation. Caffeine may also worsen sleep, anxiety, reflux, palpitations, or blood pressure in sensitive individuals, so coffee and tea should be viewed as optional additions—not essential brain-health strategies.

Physical Activity

Physical activity is another key component. Evidence suggests that both aerobic and strength training are important for preserving cognitive function:

• Strength training: Resistance training two to three times per week targeting major muscle groups improves muscle strength, which is strongly associated with cognitive benefits. Studies suggest it may improve memory, executive function, and brain plasticity in older adults with mild cognitive impairment.

• Aerobic exercise: Activities such as walking, cycling, or swimming enhance cardiovascular and metabolic health, supporting blood flow to the brain and helping reduce inflammation.

• Combination approach: For optimal brain health, older adults should combine aerobic activity, resistance training, balance exercises, and general daily movement.

Sleep, Cognitive Engagement, and Social Connection

Adequate sleep allows the brain to clear metabolic waste, while cognitive stimulation — learning, reading, problem-solving — helps maintain cognitive function. Maintaining strong social relationships has also been associated with lower cognitive decline risk.

Lifestyle Intervention Research

Research suggests that lifestyle patterns may influence cognitive decline and dementia risk, especially when several habits are combined.

In observational studies, higher saturated fat intake has been associated with greater Alzheimer’s risk, while dietary patterns such as the MIND and Mediterranean diets have been linked to slower cognitive decline and lower dementia risk.

The FINGER trial was the first large randomized controlled trial to show that a multidomain lifestyle program — including diet, exercise, cognitive training, and vascular risk management — could help preserve cognitive function in at-risk older adults.

More recently, a small 2024 randomized trial led by Dr. Dean Ornish found that intensive lifestyle changes — including a low-fat whole-food plant-based diet, exercise, stress management, social support, and selected supplements — were associated with improvements in some cognitive measures in people with mild cognitive impairment or early Alzheimer’s disease.

Although more research is needed, these studies suggest that comprehensive lifestyle interventions may support brain health by targeting several pathways at once, including vascular health, insulin resistance, inflammation, oxidative stress, the gut microbiome, and cognitive reserve.

Can Alzheimer’s Be Prevented?

There is no guaranteed prevention, but many cases may be influenced by modifiable factors:

• Maintain a healthy diet and weight

• Stay physically active

• Manage blood pressure and blood sugar

• Get sufficient sleep

• Avoid smoking

• Stay socially and mentally engaged

Key Takeaways

Alzheimer’s disease is complex and multifactorial. While age and genetics contribute, evidence shows that cardiovascular health, diet, physical activity, mental stimulation, sleep, and social engagement play important roles in long-term brain health. Early detection, managing reversible factors, and adopting long-term healthy habits are currently the best strategies to support brain health.

• Amyloid plaques are part of the disease but not the whole story

• Alzheimer’s is influenced by vascular health, metabolism, inflammation, lifestyle, and cognitive reserve

• Some memory problems are reversible

• Current medications provide modest benefits

• Long-term lifestyle habits may influence risk and disease progression

---

References

https://www.nia.nih.gov/health/alzheimers-and-dementia/understanding-different-types-dementia

Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3(3):186-191. doi:10.1016/j.jalz.2007.04.381 https://pubmed.ncbi.nlm.nih.gov/19595937/

Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(8). Published 2012 Aug 1. doi:10.1101/cshperspect.a006239 https://pmc.ncbi.nlm.nih.gov/articles/PMC3405821/

Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018 https://pubmed.ncbi.nlm.nih.gov/29653606/

Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016;8(6):595-608. Published 2016 Jun 1. doi:10.15252/emmm.201606210 https://pubmed.ncbi.nlm.nih.gov/27025652/

Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):280-292. doi:10.1016/j.jalz.2011.03.003 https://pubmed.ncbi.nlm.nih.gov/21514248/

Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer's disease: a review. 3 Biotech. 2022;12(2):55. doi:10.1007/s13205-022-03123-4 https://pmc.ncbi.nlm.nih.gov/articles/PMC8807768/

Clarke KM, Etemadmoghadam S, Danner B, et al. The Nun Study: Insights from 30 years of aging and dementia research. Alzheimers Dement. 2025;21(2). doi:10.1002/alz.14626 https://pubmed.ncbi.nlm.nih.gov/39998266/

Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572-628. doi:10.1016/S0140-6736(24)01296-0 https://doi.org/10.1016/S0140-6736(24)01296-0

World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. 2019. https://www.ncbi.nlm.nih.gov/books/NBK542796/

Reiman EM, Arboleda-Velasquez JF, Quiroz YT, et al. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020;11(1):667. Published 2020 Feb 3. doi:10.1038/s41467-019-14279-8 https://pmc.ncbi.nlm.nih.gov/articles/PMC6997393/

Liu S, Bush WS, Akinyemi RO, et al. Alzheimer disease is (sometimes) highly heritable: Drivers of variation in heritability estimates for binary traits, a systematic review. PLoS Genet. 2025;21(9). Published 2025 Sep 4. doi:10.1371/journal.pgen.1011701 https://pmc.ncbi.nlm.nih.gov/articles/PMC12419754/

Lee CJ, Hwang J, Kang CY, et al. Protective effect of controlled blood pressure on risk of dementia in low-risk, grade 1 hypertension. J Hypertens. 2021;39(8):1662-1669. doi:10.1097/HJH.0000000000002820 https://pubmed.ncbi.nlm.nih.gov/33710170/

Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord. 2009;28(1):75-80. doi:10.1159/000231980 https://pubmed.ncbi.nlm.nih.gov/19648749/

Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677 https://pmc.ncbi.nlm.nih.gov/articles/PMC6593623/

Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci. 1998;158(1):47-52. doi:10.1016/S0022-510X(98)00092-6 https://pubmed.ncbi.nlm.nih.gov/9667777/

Raven EP, Lu PH, Tishler TA, Heydari P, Bartzokis G. Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging. J Alzheimers Dis. 2013;37(1):127-136. doi:10.3233/JAD-130209 https://pubmed.ncbi.nlm.nih.gov/23792695/

Martyn CN, Barker DJ, Osmond C, Harris EC, Edwardson JA, Lacey RF. Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet. 1989;1(8629):59-62. https://pubmed.ncbi.nlm.nih.gov/2562879/

Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF. Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol. 2009;169(4):489-496. doi:10.1093/aje/kwn348 https://pmc.ncbi.nlm.nih.gov/articles/PMC2809081/

Tomljenovic L. Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link?. J Alzheimers Dis. 2011;23(4):567-598. doi:10.3233/JAD-2010-101494 https://pubmed.ncbi.nlm.nih.gov/21157018/

Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002;287(24):3230-3237. doi:10.1001/jama.287.24.3230 https://pubmed.ncbi.nlm.nih.gov/12076219/

Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol. 2003;60(2):194-200. doi:10.1001/archneur.60.2.194 https://pubmed.ncbi.nlm.nih.gov/12580703/

Morris MC, Evans DA, Tangney CC, et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr. 2005;81(2):508-514. doi:10.1093/ajcn/81.2.508 https://pubmed.ncbi.nlm.nih.gov/15699242/

Morris MC, Evans DA, Tangney CC, et al. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol. 2006;63(8):1085-1088. doi:10.1001/archneur.63.8.1085 https://pubmed.ncbi.nlm.nih.gov/16908733/

Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol. 2006;59(6):912-921. doi:10.1002/ana.20850 4https://doi.org/10.1002/ana.20854

Barnard ND, Bush AI, Ceccarelli A, et al. Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol Aging. 2014;35 Suppl 2. doi:10.1016/j.neurobiolaging.2014.03.033 https://pubmed.ncbi.nlm.nih.gov/24913896/

Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015;11(9):1007-1014. doi:10.1016/j.jalz.2014.11.009 https://doi.org/10.1016/j.jalz.2014.11.009

Morris MC, Tangney CC, Wang Y, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015-1022. doi:10.1016/j.jalz.2015.04.011 https://pubmed.ncbi.nlm.nih.gov/26086182/

Tsai JH, Tsai TY, Li H, et al. Associations between plant-based dietary patterns and risks of cognitive impairment and dementia: A systematic review and dose-response meta-analysis. J Prev Alzheimers Dis. Published online February 27, 2026. doi:10.1016/j.tjpad.2026.100521 https://pubmed.ncbi.nlm.nih.gov/41763012/

Cryan JF, O'Riordan KJ, Cowan CSM, et al. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019;99(4):1877-2013. doi:10.1152/physrev.00018.2018 https://pubmed.ncbi.nlm.nih.gov/31460832/

Zhang Y, Liu Y, Li Y, et al. Coffee and Tea Intake, Dementia Risk, and Cognitive Function. JAMA. 2026;335(11):961-974. doi:10.1001/jama.2025.27259 https://pubmed.ncbi.nlm.nih.gov/41661604/

Li F, Liu X, Jiang B, et al. Tea, coffee, and caffeine intake and risk of dementia and Alzheimer's disease: a systematic review and meta-analysis of cohort studies. Food Funct. 2024;15(16):8330-8344. Published 2024 Aug 12. doi:10.1039/d4fo01750a https://pubmed.ncbi.nlm.nih.gov/39054894/

Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911-16.e12. doi:10.1016/j.jada.2010.03.018 https://pubmed.ncbi.nlm.nih.gov/20497781/

Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011;108(7):3017-3022. doi:10.1073/pnas.1015950108 https://pubmed.ncbi.nlm.nih.gov/21282661/

Mavros Y, Gates N, Wilson GC, et al. Mediation of Cognitive Function Improvements by Strength Gains After Resistance Training in Older Adults with Mild Cognitive Impairment: Outcomes of the Study of Mental and Resistance Training. J Am Geriatr Soc. 2017;65(3):550-559. doi:10.1111/jgs.14542 https://pubmed.ncbi.nlm.nih.gov/28304092/

Bliss ES, Wong RH, Howe PR, Mills DE. Benefits of exercise training on cerebrovascular and cognitive function in ageing. J Cereb Blood Flow Metab. 2021;41(3):447-470. doi:10.1177/0271678X20957807 https://pmc.ncbi.nlm.nih.gov/articles/PMC7907999/

Bossers WJ, van der Woude LH, Boersma F, Hortobágyi T, Scherder EJ, van Heuvelen MJ. A 9-Week Aerobic and Strength Training Program Improves Cognitive and Motor Function in Patients with Dementia: A Randomized, Controlled Trial. Am J Geriatr Psychiatry. 2015;23(11):1106-1116. doi:10.1016/j.jagp.2014.12.191 https://pubmed.ncbi.nlm.nih.gov/25648055/

Ba DM, Gao X, Al-Shaar L, et al. Mushroom intake and cognitive performance among US older adults: the National Health and Nutrition Examination Survey, 2011-2014. Br J Nutr. 2022;128(11):2241-2248. doi:10.1017/S0007114521005195 https://pmc.ncbi.nlm.nih.gov/articles/PMC9661370/

Aoki S, Yamagishi K, Maruyama K, et al. Mushroom intake and risk of incident disabling dementia: the Circulatory Risk in Communities Study (CIRCS). Br J Nutr. 2024;131(9):1641-1647. doi:10.1017/S000711452400014X https://pubmed.ncbi.nlm.nih.gov/38239014/

Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304(17):1903-1911. doi:10.1001/jama.2010.1510 https://pubmed.ncbi.nlm.nih.gov/21045096/

Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010;5(9). Published 2010 Sep 8. doi:10.1371/journal.pone.0012244 https://pubmed.ncbi.nlm.nih.gov/20838622/

Kivipelto M, Solomon A, Ahtiluoto S, et al. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 2013;9(6):657-665. doi:10.1016/j.jalz.2012.09.012

https://pubmed.ncbi.nlm.nih.gov/23332672/

Ornish D, Madison C, Kivipelto M, et al. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial. Alzheimers Res Ther. 2024;16(1):122. Published 2024 Jun 7. doi:10.1186/s13195-024-01482-z https://pubmed.ncbi.nlm.nih.gov/38849944/

https://www.alz.org/alzheimers-dementia/stages, Accessed March 17, 2026